We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alizyme | LSE:AZM | London | Ordinary Share | GB0000374289 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.08 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/8/2009 15:10 | No mm - the tax losses are only available if you have offsettable profits in the same sector - ie bio drugs - how many companies fit that bill?! This may give some cash back to Pi's - but nothing like the 20p per share - if anyone is confident of this - would they like my shares for 10p per share (some 30,000) today - 100% profit straight away with the div payment!? | dunderheed | |
24/8/2009 14:53 | Given that the company raised in total £131M, and just about have blown the whole lot, does that mean the accumulated tax loss is about the same. At 30% corporation tax, does that mean AZM is worth up to £40M to any buyer wanting to offet tax (assuming there are some companies out there that have taxable profits!). If so that is 20p a share, with anything in the drug portfolio being icing on the top. Had you done that calculation, Dunderheed? | mad mike | |
24/8/2009 14:19 | Because there is nothing to justify a 20p per share cash divi - if this was the case do you really think the management would have folded so easily - I turn the question back to you and suggest it better he/she give some justification to the 20p per share div? At this stage - the majority of the worth of this company is in tax losses racked up by team liar - I would imagine?! | dunderheed | |
24/8/2009 14:09 | Well whats wrong with with ant 15's comment maybe you don't owe shares Dund,you can either prove him wrong or sustain you 1p argument thats all. | gambill | |
24/8/2009 13:49 | Or it could be 1p per share? If that>?! | dunderheed | |
24/8/2009 12:59 | capricious Its a plc and as such shares can still be traded. It would be interesting to know who bought them not thats its a large amount financially. Anyway you chaps....If this is sold peacemeal we might see something well in excess of the last traded shareprice for a split of its assets. Ironic but they could be 6-8 times the market cap giving rise to a cash divi of up to 20p per share. Fingers crossed do your own etc. | ant15 | |
11/8/2009 14:34 | Stange, a transaction of 132991 today, thought all activity was suspended... | capricious | |
10/8/2009 22:00 | Thank you for your reply mike. The litigation on this one is worth how much? That would appear a liability on the balance sheet, I mean a contingent one would it not? TIA | silverbackalpha | |
10/8/2009 15:43 | loafingchard....plea | romust | |
10/8/2009 14:39 | Go away Victor , no one likes you . Why won't it sink in ? | loafingchard | |
10/8/2009 13:24 | If the shares become valueless and AZM don't have any loans as far as I see and the assets if there is any are sold who gets the money (profit)! I think that would be the share holders / owners! | mole16 | |
10/8/2009 12:43 | Sorry to go over old ground here, but what was the size of the claim and what would be the VAT liability, tax liabs and other debts to repay. i have never known of a shareholder to get any money on the windup/administratio in fact as I understand it, companies go into administrated when the shares are becoming valualess. | silverbackalpha | |
10/8/2009 12:14 | geoff, yes, RP should have sealed deals when there was hype But, dont forget, if things had gone right, they could have made a much bigger company by hanging on. Takeda is spending money on Japanese trials. The US is indepenent of that. Sure, positive results would help, but there is a real risk that forecast sales will not be high enough to warrant the development cost - or there wasnt when AZM also wanted a slice. I think Takeda will pick up US rights for a small sum sadly. | the_doctor | |
08/8/2009 10:58 | "I tell you man" What are you twelve? | vow | |
08/8/2009 10:22 | Actually mad mike - just want to go on record as stating they imho VOW/victor/silver etc were all as bad as one another - just with different angles/agendas/issue It goes to show you what an emotive board this was - people are still posting on here well after the death knell - still arguing amongst themselves - class!! | dunderheed | |
07/8/2009 19:46 | incidentally i would be getting out of herlad here btw. | silverbackalpha | |
07/8/2009 13:48 | Doc you say that you doubt anyone would take up ceti because of the cost involved....how much have Takeda spent on these endless trials I wonder. I certainly do not think you are wrong,but something does not add up. I posted months/years ago that AZM were being squeezed,and so it proved. I actually made about £20k on AZM over the years,and that is after giving back nearly £15k after the "transforming deals across the whole portfolio by the end of the year" fiasco.....That is what made me get out completely. RP is probably the person I blame the most,as he should have completed deals in the early days,but he believed Ceti etc were worth more than the market thought........Sorry guys,and good luck. | geoffmanana | |
07/8/2009 12:45 | Either that, or to point the fact out mole. | romust |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions